ID: ALA326230
Chembl Id: CHEMBL326230
PubChem CID: 5746239
Max Phase: Preclinical
Molecular Formula: C22H20N4O5S
Molecular Weight: 452.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCS(=O)(=O)Nc1ccc(Nc2c3ccccc3nc3cc([N+](=O)[O-])ccc23)c(OC)c1
Standard InChI: InChI=1S/C22H20N4O5S/c1-3-32(29,30)25-14-8-11-19(21(12-14)31-2)24-22-16-6-4-5-7-18(16)23-20-13-15(26(27)28)9-10-17(20)22/h4-13,25H,3H2,1-2H3,(H,23,24)
Standard InChI Key: BCPPFWWVLOMAOB-UHFFFAOYSA-N
Alternative Forms:
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 452.49 | Molecular Weight (Monoisotopic): 452.1154 | AlogP: 4.81 | #Rotatable Bonds: 7 |
| Polar Surface Area: 123.46 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 11.10 | CX Basic pKa: 6.20 | CX LogP: 3.61 | CX LogD: 3.58 |
| Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.23 | Np Likeness Score: -1.58 |
| 1. Denny WA, Cain BF, Atwell GJ, Hansch C, Panthananickal A, Leo A.. (1982) Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents., 25 (3): [PMID:7069706] [10.1021/jm00345a015] |
| 2. Prakash R, Goodlett DW, Varghese S, Andrys J, Gbadamosi FA, Arriaza RH, Patel M, Tiwari PB, Borowski T, Chruszcz M, Shimizu LS, Upadhyay G.. (2023) Development of fluorophore labeled or biotinylated anticancer small molecule NSC243928., 79 [PMID:36680947] [10.1016/j.bmc.2023.117171] |
Source(1):
